drugset / Trial / NCT00863265
Phytosterols, Ezetimibe, and Cholesterol Metabolism
Phase 0
Completed
22 enrolled
Washington University School of Medicine
National Heart, Lung, and Blood Institute (NHLBI) · collabUtah State University · collab
RandomizedCrossoverQuadruple-blindBasic science
Summary
Phytosterols and ezetimibe each reduce intestinal cholesterol absorption by 30-55% but appear to have different mechanisms of action. The investigators' hypothesis is that phytosterols and ezetimibe given together will block cholesterol absorption in an additive fashion. In a randomized, placebo-controlled crossover trial the effects of placebo, ezetimibe treatment and ezetimibe plus phytosterol treatment will be measured.
Timeline
- Start
- 2009-06
- Primary completion
- 2009-10
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ezetimibe | Unknown | 10 mg | — |